Avalere Health, a market research and consulting firm, estimates some consumers will pay half the cost of their specialty drugs under health overhaul-related plans, while customers in the private market typically pay no more than a third. Patient advocates worry that insurers may be trying to discourage chronically ill patients from enrolling by putting high cost drugs onto specialty tiers.
Under the law, insurers can't charge an individual more than $6,350 in out-of pocket costs a year and no more than $12,700 for a family policy. But patients advocates warn those with serious illnesses could pay their entire out-of-pocket cap before their insurance kicks in any money.
Insurers say prescription drugs are one of the main reasons health care costs are rising.
One of the goals of health care reform should be to "bend the cost curve." One of the ways that Obamacare is trying to achieve that is to force consumers to pay more for prescription drugs.
This comes on the heels of a separate Avalere report this month that, aside from prescription drugs, premiums overall will skyrocket.